Filing metadata

Accession number
0001214659-20-000359
Form type
Form 3
Filer
Mirati Therapeutics, Inc.
CIK
CIK 1576263
Filed
Jan 15, 2020
Reporting period
Jan 06, 2020
Description
Initial ownership

Explore SEC Filings Hub